Symmetric bis-chalcones as a new type of breast cancer resistance protein inhibitors with a mechanism different from that of chromones.
about
Anti-tumor activity of SL4 against breast cancer cells: induction of G2/M arrest through modulation of the MAPK-dependent p21 signaling pathway.Diverse Molecular Targets for Chalcones with Varied Bioactivities.SL4, a chalcone-based compound, induces apoptosis in human cancer cells by activation of the ROS/MAPK signalling pathway.Phenolic indeno[1,2-b]indoles as ABCG2-selective potent and non-toxic inhibitors stimulating basal ATPase activity.Practical Synthesis of Chalcone Derivatives and Their Biological Activities.A Way to Improve Luminescent Efficiency of Bis-Chalcone Derivatives
P2860
Symmetric bis-chalcones as a new type of breast cancer resistance protein inhibitors with a mechanism different from that of chromones.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Symmetric bis-chalcones as a n ...... ferent from that of chromones.
@en
Symmetric bis-chalcones as a n ...... ferent from that of chromones.
@nl
type
label
Symmetric bis-chalcones as a n ...... ferent from that of chromones.
@en
Symmetric bis-chalcones as a n ...... ferent from that of chromones.
@nl
prefLabel
Symmetric bis-chalcones as a n ...... ferent from that of chromones.
@en
Symmetric bis-chalcones as a n ...... ferent from that of chromones.
@nl
P2093
P356
P1476
Symmetric bis-chalcones as a n ...... ferent from that of chromones.
@en
P2093
Attilio Di Pietro
Charlotte Gauthier
Louise Domeneghini Chiaradia-Delatorre
Patrícia Devantier Neuenfeldt
Ricardo José Nunes
Rosendo Augusto Yunes
Tânia Beatriz Creczynski-Pasa
P304
P356
10.1021/JM401879Z
P407
P577
2014-03-24T00:00:00Z